ACM
LFCR icon

Argent Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Argent Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-147,125
Closed -$1.8M – 179
2014
Q3 		$1.8M Buy
147,125
+40,175
+38% +$502K 0.1% 102
2014
Q2 		$1.34M Buy
106,950
+2,025
+2% +$23.8K 0.07% 124
2014
Q1 		$1.17M Hold
104,925
– – 0.06% 126
2013
Q4 		$1.27M Buy
104,925
+46,500
+80% +$555K 0.07% 120
2013
Q3 		$713K Buy
+58,425
New +$815K 0.04% 124

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Argent Capital Management's LFCR Position: Q4 2014 in Review

Argent Capital Management sold out of Lifecore Biomedical (LFCR) in Q4 2014, closing a stake of 147,125 shares — an estimated $1.8M sold.

Argent Capital Management first reported a position in LFCR in Q3 2013 and held it in 5 quarters. The position peaked at $1.8M in Q3 2014. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2014.

  • Argent Capital Management reported no remaining Lifecore Biomedical position as of Q4 2014 after selling out during the quarter.
  • Argent Capital Management sold 147,125 Lifecore Biomedical shares in Q4 2014, an estimated $1.8M.
  • Argent Capital Management first reported a position in Lifecore Biomedical in Q3 2013 and held it in 5 quarters.
  • Argent Capital Management's Lifecore Biomedical position peaked at $1.8M in Q3 2014.
  • 109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2014.

Based on Argent Capital Management's 13F filing for Q4 2014, filed 6 Feb 2015.